Moksnes, Marta R. http://orcid.org/0000-0002-2690-5153
Graham, Sarah E. http://orcid.org/0000-0003-1271-2489
Wu, Kuan-Han http://orcid.org/0000-0003-4286-4299
Hansen, Ailin Falkmo
Gagliano Taliun, Sarah A. http://orcid.org/0000-0003-1306-1868
Zhou, Wei http://orcid.org/0000-0001-7719-0859
Thorstensen, Ketil
Fritsche, Lars G. http://orcid.org/0000-0002-2110-1690
Gill, Dipender http://orcid.org/0000-0001-7312-7078
Mason, Amy http://orcid.org/0000-0002-8019-0777
Cucca, Francesco
Schlessinger, David
Abecasis, Gonçalo R. http://orcid.org/0000-0003-1509-1825
Burgess, Stephen
Åsvold, Bjørn Olav http://orcid.org/0000-0003-3837-2101
Nielsen, Jonas B.
Hveem, Kristian
Willer, Cristen J. http://orcid.org/0000-0001-5645-4966
Brumpton, Ben M. http://orcid.org/0000-0002-3058-1059
Article History
Received: 21 September 2021
Accepted: 24 May 2022
First Online: 16 June 2022
Change Date: 22 August 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Competing interests
: The authors declare the following competing interests: D.G. is employed part-time by Novo Nordisk outside the submitted work. G.R.A. and J.B.N. work for Regeneron Pharmaceuticals. C.J.W.‘s spouse works for Regeneron Pharmaceuticals. The remaining authors declare no competing interests.